|
Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus Clinical research trials and Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus. Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus clinical trial. Participants typically obtain the most effective healthcare available for their Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
For Condition: Diabetes Mellitus, Non-Insulin-Dependent
Status: No longer recruiting
Sponsor(s): Amylin Pharmaceuticals ,
Synopsis: This is a multicenter, randomized, blinded, placebo-controlled, short-term, dose-response study to examine the effects on glucose control of AC2993 as compared to placebo in patients with type 2 diabetes. Patients will be individuals with type 2 diabetes treated with metformin for at least 3 months prior to screening. Patients whose diabetes management consists of diet and exercise will also be eligible for this study.
Details:
Eligibility:
Study Type: Interventional, Treatment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Subjects with type 2 diabetes - Treated with diet and exercise alone or with metformin for at least 3 months prior to screening - BMI 27-45 kg/m^2 - HbA1c between 7.0 % and 8.0 % Exclusion Criteria: - Treated with other oral anti-diabetic agents other than metformin within 3 months of screening - Patients previously treated with AC2993 - Patients presently treated with insulin
Total Enrollment:
Location and Contact Information:
Cedar-Crosse Research Center
Chicago, Illinois, 60607
United States
International Clinical Research Network
Chula Vista, California, 91910
United States
Clinical Research Group of North Georgia
Blairsville, Georgia, 30512
United States
Utah Diabetes Center at the University of Utah
Salt Lake City, Utah, 84108
United States
Radiant Research-Pinellas Park
Pinellas Park, Florida, 33781
United States
The Center for Pharmaceutical Research
Kansas City, Missouri, 64114
United States
Diabetes Center of the Southwest
Midland, Texas, 79705
United States
Millenium Research
Benbrook, Texas, 76126
United States
Carolina Advanced Research
Cary, North Carolina, 27511
United States
Healthsouth Clinical Research
Birmingham, Alabama, 35243
United States
Northshore Medical Research, LLC
Covington, Louisiana, 70433
United States
Diagnostic Clinic
Clearwater, Florida, 33760
United States
Baylor College of Medicine/Clinical Studies Unit
Houston, Texas, 77030
United States
Medical Research Institute
Slidell, Louisiana, 70458
United States
Radiant Research-Edina
Edina, Minnesota, 55435
United States
Innovative Health Research
Las Vegas, Nevada, 89119
United States
Innovative Clinical Trials
Birmingham, Alabama, 35209
United States
Anshutz Outpatient Pavilion
Aurora, Colorado, 80010
United States
Pioneer Medical Group
Bellflower, California, 90706
United States
East-West Medical Research Institute
Honolulu, Hawaii, 96813
United States
Radiant Research-Boise
Boise, Idaho, 83704
United States
Melvin Kramer, MD
Concord, Massachusetts, 01742
United States
Radiant Research-Gainsville
Gainesville, Florida, 32605
United States
Radiant Research-Honolulu
Honolulu, Hawaii, 96814
United States
Jacksonville Center for Clinical Research
Jacksonville, Florida, 32216
United States
Fallen Timbers Internal Medicine, LLC
Maumee, Ohio, 43537
United States
Richard Cherlin, M.D.
Los Gatos, California, 95032
United States
Whittier Institute for Diabetes
La Jolla, California, 92037
United States
Endocrinology Clinic of O.C.
Anaheim, California, 92801
United States
Healthsouth Clinical Research
Desoto, Texas, 75115
United States
Dr. Martinez Medical Clinic
Moreno Valley, California, 92553
United States
Bautista Research and Medical Clinic
Fresno, California, 93721
United States
Mississippi Medical Research, LLC
Gulfport, Mississippi, 39501
United States
Additional Information:
Study ID Numbers: 2993-116;
Study Start Date:
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00044694
Other Diabetes Mellitus, Non-Insulin-Dependent Studies:
1. An evaluation of an oral antidiabetic agent for the treatment of type 2 diabetes
2. Education and Group Support for Diabetic Hispanics
3. A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes
4. Evaluation of an Orally Administered Medication When Taken in Conjunction with Pramlintide
5. Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
Related Studies:
Other Diabetes Mellitus, Non-Insulin-Dependent Clinical Trials
Other Georgia Clinical Trials
Other Blairsville Clinical Trials
Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
|
|
|
|
|
|
|
|